Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma

Autor: Kröger, Nicolaus *, Perez-Simon, Jose A., Myint, Han, Klingemann, Hans, Shimoni, Avichai, Nagler, Arnon, Martino, Rodrigo, Alegre, Adrian, Tomas, Jose F., Schwerdtfeger, Rainer, Kiehl, Michael, Fauser, Axel, Sayer, Herbert Gottfried, Leon, Angel, Beyer, Jörg, Zabelina, Tatjana, Ayuk, Francis, San Miguel, Jesus F., Brand, Ronald, Zander, Axel Rolf
Zdroj: In Biology of Blood and Marrow Transplantation 2004 10(10):698-708
Databáze: ScienceDirect
Externí odkaz: